Previous Close | 499.09 |
Open | 507.85 |
Bid | 455.68 x 1000 |
Ask | 616.50 x 800 |
Day's Range | 503.48 - 518.20 |
52 Week Range | 468.86 - 832.70 |
Volume | |
Avg. Volume | 233,951 |
Market Cap | 15.382B |
Beta (5Y Monthly) | 0.91 |
PE Ratio (TTM) | 2.33 |
EPS (TTM) | 220.48 |
Earnings Date | Apr 27, 2022 - May 02, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 711.67 |
How far off is Bio-Rad Laboratories, Inc. ( NYSE:BIO ) from its intrinsic value? Using the most recent financial data...
Bio-Rad's (BIO) first-quarter 2022 revenues decline year over year due to lower COVID-related demand.
Bio-Rad (BIO) delivered earnings and revenue surprises of 76.43% and 3.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?